Emotion-Focused Therapy in the Treatment of Prolonged Grief Disorder
EFT-PGD
1 other identifier
interventional
128
1 country
1
Brief Summary
The goal of this clinical trial is to learn if Emotion-Focused Therapy (EFT) works to reduce symptoms of Prolonged Grief Disorder (PGD) in adults. PGD happens when the pain of losing a loved one lasts a long time and causes serious problems in daily life.
- All participants will complete questionnaires on grief, mood, and well-being before starting, during the study, at the end of treatment (12 weeks), and again at 5 months and 12 months after starting.
- In the EFT group, the therapeutic relationship will also be measured during sessions 3 and 8.
- Why this study is important: Most current treatments for grief are based on cognitive-behavioral therapy, but not everyone benefits from them. EFT is a promising therapy that focuses on emotions and has shown positive results for other mental health problems. This trial will test if EFT can be an effective treatment for people struggling with prolonged grief.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2025
CompletedFirst Posted
Study publicly available on registry
October 6, 2025
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
Study Completion
Last participant's last visit for all outcomes
December 1, 2027
December 4, 2025
September 1, 2025
Same day
September 26, 2025
November 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prolonged Grief Scale 13 - Revised
Higher scores indicate greater symptomatology of Prolonged Grief Disorder; a score of 30 or higher meets the clinical threshold for Prolonged Grief Disorder.
From enrollment to the end of the research at 1 year follow-up
Secondary Outcomes (4)
Centrality of Event Scale
From enrollment to the end of the reserch at 1 year follow-up
Clinical Outcomes in Routine Evaluation-10
From enrollment to the end of the reserch at 1 year follow-up
Patients Health Questionnarie 9
From enrollment to the end of the reserch at 1 year follow-up
Generalized Anxiety Disorder-7 Scale
From enrollment to the end of the reserch at 1 year follow-up
Study Arms (2)
Emotion-Focused Therapy for Grief
EXPERIMENTALself-help intervention based on Emotion-Focused Therapy
PLACEBO COMPARATORInterventions
The EFT intervention will follow the model described in EFT for grief. Its main goal is to transform core emotional pain (e.g., chronic shame) by activating change-inducing emotions (e.g., assertive anger), a process described as "changing emotion with emotion." This work takes place within a safe and supportive therapeutic relationship, characterized by the therapist's empathic, accepting, and compassionate stance. Therapists remain attuned to emotional markers (e.g., self-criticism, unfinished business) that signal opportunities for targeted work on specific affective problems, which are usually addressed through experiential tasks such as the Empty-Chair for Unfinished Business. Although EFT is transdiagnostic, grief work has certain distinctive features, such as the central role of experiencing grief-related sadness and fostering a sense of connection with the deceased.
The self-help intervention consists of 10 written exercises designed to address different aspects of grief. These include psychoeducation, emotional regulation, focusing on bodily awareness, softening self-criticism, reducing avoidance, managing anxiety and fear, clarifying confusing emotional reactions, processing trauma, imaginal dialogues with the deceased, and cultivating compassion.
Eligibility Criteria
You may qualify if:
- Adults (≥18 years).
- Undergoing a grief process (including perinatal grief).
- Meeting diagnostic criteria for Prolonged Grief Disorder (bereavement occurring six months or more prior to the loss; PG-13-R score ≥30).
- Provision of informed consent.
- Stable psychopharmacological medication for at least six weeks prior to therapy onset, with physician approval to maintain stability during the intervention.
You may not qualify if:
- Concurrent psychological treatment
- Bereavement occurring less than six months prior to the loss
- Substance abuse
- Eating disorder
- Psychosis;
- Organic brain syndrome
- Suicide risk
- Risk of harm to others.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unidad Clínica de Psicología de la Universidad Pontificia Comillas (UNINPSI)
Madrid, Madrid, 28036, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
José Gamoneda, PhD
Universidad Pontificia Comillas
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
September 26, 2025
First Posted
October 6, 2025
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 1, 2027
Last Updated
December 4, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share